Skip to content
10-Q

Quarterly Report

Akero Therapeutics, Inc.

0001193125-25-176038

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 79.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 81.72M sh
Shares Diluted Q2 2025 · Jun 30, 2025 80.2M sh
Shares Diluted Q2 2025 · Jun 30, 2024 69.16M sh
Shares Diluted Q2 2025 · Jun 30, 2024 64.23M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$115.91M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$92.59M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $220.45M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $340.24M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.03B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.08B
Stockholders Equity Q2 2025 · Dec 31, 2024 $750.11M
Stockholders Equity Q2 2025 · Jun 30, 2024 $798.07M
Stockholders Equity Q2 2025 · Mar 31, 2024 $846.25M
Stockholders Equity Q2 2025 · Dec 31, 2023 $535.31M
Current Liabilities Q2 2025 · Jun 30, 2025 $60.4M
Current Liabilities Q2 2025 · Dec 31, 2024 $39.75M
Total Liabilities Q2 2025 · Jun 30, 2025 $83.33M
Total Liabilities Q2 2025 · Dec 31, 2024 $75.77M
Current Assets Q2 2025 · Jun 30, 2025 $764.6M
Current Assets Q2 2025 · Dec 31, 2024 $770.38M
Total Assets Q2 2025 · Jun 30, 2025 $1.11B
Total Assets Q2 2025 · Dec 31, 2024 $825.89M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.86
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.76
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.81
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.70
Eps Basic Q2 2025 · Jun 30, 2025 −$0.86
Eps Basic Q2 2025 · Jun 30, 2025 −$1.76
Eps Basic Q2 2025 · Jun 30, 2024 −$0.81
Eps Basic Q2 2025 · Jun 30, 2024 −$1.70
Sga Expense Q2 2025 · Jun 30, 2025 $11.62M
Sga Expense Q2 2025 · Jun 30, 2025 $22.93M
Sga Expense Q2 2025 · Jun 30, 2024 $10.42M
Sga Expense Q2 2025 · Jun 30, 2024 $19.72M
Rd Expense Q2 2025 · Jun 30, 2025 $69.25M
Rd Expense Q2 2025 · Jun 30, 2025 $138.82M
Rd Expense Q2 2025 · Jun 30, 2024 $55.32M
Rd Expense Q2 2025 · Jun 30, 2024 $105.97M
Net Income Q2 2025 · Jun 30, 2025 −$70.51M
Net Income Q2 2025 · Jun 30, 2025 −$141.23M
Net Income Q2 2025 · Mar 31, 2025 −$70.73M
Net Income Q2 2025 · Dec 31, 2024 −$252.06M
Net Income Q2 2025 · Jun 30, 2024 −$55.99M
Net Income Q2 2025 · Jun 30, 2024 −$109.33M
Net Income Q2 2025 · Mar 31, 2024 −$53.34M
Net Income Q2 2025 · Dec 31, 2023 −$151.76M
Operating Income Q2 2025 · Jun 30, 2025 −$80.87M
Operating Income Q2 2025 · Jun 30, 2025 −$161.76M
Operating Income Q2 2025 · Jun 30, 2024 −$65.74M
Operating Income Q2 2025 · Jun 30, 2024 −$125.7M